
Reset all filters
01 4AstraZeneca Canada Inc.
Reset all filters
01 22701057
02 22869936
Reset all filters
01 4CAPIVASERTIB
Reset all filters
01 4TABLET
Reset all filters
01 22028-10-09
02 22033-04-16
Patent Expiration Date : 2028-10-09
Date Granted : 2015-03-24
Brand Name : TRUQAP
Patent Number : 2701057
Filing Date : 2008-10-09
Strength per Unit : 160 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2028-10-09
Date Granted : 2015-03-24
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2033-04-16
Date Granted : 2020-07-28
Brand Name : TRUQAP
Patent Number : 2869936
Filing Date : 2013-04-16
Strength per Unit : 160 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2033-04-16
Date Granted : 2020-07-28
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2028-10-09
Date Granted : 2015-03-24
Brand Name : TRUQAP
Patent Number : 2701057
Filing Date : 2008-10-09
Strength per Unit : 200 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2028-10-09
Date Granted : 2015-03-24
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2033-04-16
Date Granted : 2020-07-28
Brand Name : TRUQAP
Patent Number : 2869936
Filing Date : 2013-04-16
Strength per Unit : 200 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2033-04-16
Date Granted : 2020-07-28
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF